GEN-MKT-18-7897-A
Jul 14, 2025 | Blogs, Environmental / Industrial, Food and Beverage, Industrial, SCIEX OS software | 0 comments
Read time: 3 minutes
As PFAS regulations tighten globally, laboratory managers are navigating a complex economic landscape. Whether operating in a commercial or non- commercial setting, the pressure to deliver accurate, defensible, and timely PFAS data is mounting. At SCIEX we understand that the right technology can turn this regulatory challenge into a strategic opportunity.
What lab managers need to know about commercial vs. non- commercial models
As a lab manager, understanding the operational dynamics of different lab types is key to making strategic decisions, especially when it comes to PFAS testing.
Commercial testing
If you are managing a commercial lab your focus is on delivering fast, accurate, and defensible PFAS results while maintaining profitability. This means investing in high-throughput technologies, optimizing workflows, and training your team to meet tight turnaround times and evolving regulatory demands. Efficiency and scalability are your competitive edge.
Non- commercial labs
In academic, government, or public research labs, this mission is different, but no less demanding. Your lab plays a critical role in advancing PFAS science, supporting public health and informing policy. The emphasis is on generating high-quality peer reviewed data that can withstand scientific scrutiny. Timelines still matter, but so does depth and reproducibility.
Why it matters?
Regardless of your lab’s model the expectations are the same: precision, reliability and adaptability. Investing in mass spectrometry- and building a skilled, well supported team are essential to stay ahead in a complex fast-moving world of PFAS testing.
SCIEX mass spectrometry platforms are engineered for labs that need to balance cost-efficiency, regulatory compliance, and analytical excellence. Here’s how SCIEX supports both commercial and non-commercial labs:
For commercial labs, this means faster ROI and greater client satisfaction. For non-commercial labs, it means scientific credibility and methodological flexibility.
PFAS science is evolving rapidly. New compounds, new matrices and new regulations. Labs that invest in flexible, scalable platforms are best equipped to adapt.
SCIEX offers:
As a lab manager, every hour of downtime impacts your throughput, turnaround times, and bottom line. With PFAS testing under increasing regulatory pressure, system reliability isn’t option, it is essential!
Here’s how SCIEX service and support can help you stay productive and profitable:
Regularly serviced systems perform better- delivering more results consistently
SCIEX-trained engineers and specialists can quickly resolve issues, reducing costly delays
Whether you are running our latest Zeno TOF 8600 system or one of our nominal mass systems, our support is customized to your instrument and workflows.
Maximize your ROI with longer instrument life, fewer disruptions, and consistently high data quality
The economics of PFAS testing demand strategic thinking. Laboratory managers must balance cost, compliance, and capacity while preparing for a dynamic regulatory future. SCIEX mass spectrometry platforms offer the precision, productivity and partnership needed to turn PFAS testing into a sustainable opportunity.
Explore how SCIEX can help you lead in PFAS analysis
Discover more >
The Echo® MS+ system is a novel platform for Acoustic Ejection Mass Spectrometry (AEMS) and combines the speed of acoustic sampling with the selectivity of mass spectrometry. This platform has been designed for high throughput analysis of small and large molecules. The technology combines Acoustic Droplet Ejection (ADE), an Open Port Interface (OPI) and could be coupled with the SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system.
The Echo® MS+ system comprises of an open-port interface (OPI) and acoustic droplet ejection (ADE) module which could be coupled with a mass spectrometer. The mass spectrometer could either be a SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system. This non-liquid chromatography based; high-throughput screening platform enables rapid analysis of compounds at speeds of up to 1 sample/second.
The ability to consistently achieve reproducible results on many complex samples across multiple days is critical to a routine clinical laboratory. Laboratories relying on analytical instrumentation require stability and robustness to perform a variety of screening and confirmatory assays with confidence. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the preferred analytical method in the clinical laboratory to reliably perform clinical testing as it provides best-in-class performance and reliability for the most challenging assays. LC-MS/MS offers the required levels of sensitivity and specificity for the detection and quantitation of molecules from complex biological samples, helping laboratories deliver highly accurate data for a variety of clinically relevant analytes across a wide range of assays.
Posted by
You must be logged in to post a comment.
Share this post with your network